Previous 10 | Next 10 |
2023-06-21 15:44:13 ET Aethlon Medical ( NASDAQ: AEMD ) said it is investigating using its Hemopurifier device to remove harmful viruses and exosomes from harvested organs, which could help reduce complications associated with organ transplantation. The medical device developer ...
Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation PR Newswire Research to Confirm the Hemopurifier's Ability to Remove Harmful Viruses and Exosomes From Harvested Organs SAN DIEGO , June 21, 2023 /PRNewswir...
Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest PR Newswire SAN DIEGO , June 14, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing produ...
Aethlon Medical to Present at the 13th Annual LD Micro Invitational PR Newswire SAN DIEGO , June 1, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threa...
Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India PR Newswire SAN DIEGO , May 22, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therap...
2023-04-24 13:15:26 ET This is a significant week for earnings, and mega-cap tech names will headline what’s sure to be a volatile week. Next week, the action continues with the upcoming Fed meeting and another rate hike decision. Some traders are flocking toward cheaper stocks in li...
Aethlon Medical, Inc. (AEMD) Q3 2023 Earnings Conference Call February 13, 2023, 04:30 PM ET Company Participants Jim Frakes - Chief Financial Officer Steven LaRosa - Chief Medical Officer Guy Cipriani - Chief Business Officer Conference Call Participants M...
Aethlon Medical press release ( NASDAQ: AEMD ): Q3 GAAP EPS of -$0.12 misses by $0.04 . As of December 31, 2022, Aethlon Medical had a cash balance of approximately $17.5 million. Aethlon did not record government contract revenue in the three months ended December 31, 202...
Aethlon Medical to Present at Sequire Biotechnology Conference on February 2nd, 2023 PR Newswire Presentation on Thursday, February 2nd, 2023 at 10:00 AM ET SAN DIEGO , Jan. 31, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a company ...
3 Technical Indicators to Use to Find Penny Stocks to Buy Technical indicators are used to analyze past and current stock price data to predict future performance. They can help investors make informed decisions about when to buy and sell penny stocks . Technical indicators provide inform...
News, Short Squeeze, Breakout and More Instantly...
2024-06-28 12:40:00 ET SAN DIEGO - June 28, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal ye...
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update PR Newswire Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Na...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...